Accelerated Clinical Trial Agreement Template for the Netherlands

An Accelerated Clinical Trial Agreement is a specialized legal contract that governs expedited clinical research in the Netherlands. This document establishes the legal framework between pharmaceutical companies, clinical research institutions, hospitals, and principal investigators when conducting time-sensitive medical research that requires rapid implementation and completion.

When do you need this document?

You need this agreement when conducting clinical trials that require expedited timelines due to urgent medical needs, public health emergencies, or critical therapeutic developments. This includes pandemic response studies, breakthrough therapy investigations, emergency use authorization trials, and research addressing unmet medical needs with significant public health impact. The agreement is also essential when regulatory authorities have designated your study for accelerated assessment pathways or when you're conducting trials under emergency protocols that deviate from standard timelines.

Key legal considerations

The agreement must address accelerated recruitment strategies while maintaining informed consent standards and patient safety protocols. Critical clauses include expedited ethics committee review processes, compressed monitoring schedules, and rapid data collection and analysis timelines. You must establish clear liability allocation between parties, especially regarding accelerated decision-making processes and potential protocol deviations. The contract should specify enhanced communication requirements, emergency contact procedures, and escalation pathways for adverse events. Financial provisions must account for accelerated resource deployment, overtime requirements, and potential cost overruns associated with expedited operations.

Legal requirements in Netherlands

Your accelerated clinical trial must comply with EU Clinical Trials Regulation (EU) No 536/2014, which provides harmonized assessment procedures that can support expedited reviews. The Dutch Medical Research Involving Human Subjects Act (WMO) governs ethics committee approval requirements, and you must obtain expedited review from accredited Medical Research Ethics Committees (MRECs). GDPR compliance is mandatory for all health data processing, with special attention to data minimization principles during accelerated collection phases. The agreement must reference the Dutch Medicines Act (Geneesmiddelenwet) for investigational medicinal product regulations and include provisions for reporting to the Dutch Health and Youth Care Inspectorate (IGJ). You must also ensure compliance with Good Clinical Practice guidelines while accommodating accelerated timelines and enhanced monitoring requirements specific to urgent research contexts.